Literature DB >> 2653936

Normalization of insulin sensitivity with lithium in diabetic rats.

L Rossetti1.   

Abstract

Lithium salts are commonly used in psychiatric patients and have been shown to have an insulinlike action in vitro. To define the impact of lithium ion on in vivo glucose metabolism, the effect of 2 wk of lithium treatment on plasma glucose and insulin concentrations, insulin-mediated glucose disposal, and skeletal muscle glycogen synthesis in normal and diabetic rats was examined. Our results demonstrated the ability of lithium ions to completely restore insulin sensitivity to normal in diabetic rats. The insulin-mimetic activity of the cation seems to be highly specific for the glycogenic pathway in skeletal muscle. These results raise the possibility that lithium ion may prove effective in reversing the defect in glycogen storage that characterizes non-insulin-dependent diabetes mellitus in humans.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653936     DOI: 10.2337/diab.38.5.648

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats.

Authors:  B B Kahn; L Rossetti; H F Lodish; M J Charron
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.

Authors:  L Rossetti; A Giaccari
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

3.  Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats.

Authors:  A Giaccari; L Rossetti
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  Effect of lithium on plasma glucose, insulin and glucagon in normal and streptozotocin-diabetic rats: role of glucagon in the hyperglycaemic response.

Authors:  O G Hermida; T Fontela; M Ghiglione; L O Uttenthal
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

Review 5.  Glycogen synthase kinase 3: more than a namesake.

Authors:  Geetha Vani Rayasam; Vamshi Krishna Tulasi; Reena Sodhi; Joseph Alex Davis; Abhijit Ray
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

Review 6.  Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs.

Authors:  Jeffrey Fessel
Journal:  Alzheimers Dement (N Y)       Date:  2019-11-16

7.  Microdose Lithium Protects against Pancreatic Islet Destruction and Renal Impairment in Streptozotocin-Elicited Diabetes.

Authors:  Jiahui Zhang; Fnu Anshul; Deepak K Malhotra; Juan Jaume; Lance D Dworkin; Rujun Gong
Journal:  Antioxidants (Basel)       Date:  2021-01-19

Review 8.  Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder.

Authors:  Iain H Campbell; Harry Campbell; Daniel J Smith
Journal:  Transl Psychiatry       Date:  2022-08-29       Impact factor: 7.989

9.  Downregulation of vascular endothelial growth factor receptor-2 under oxidative stress conditions is mediated by β-transduction repeat-containing protein via glycogen synthase kinase-3β signaling.

Authors:  Wen Wu; Daimin Zhang; Daorong Pan; Guangfeng Zuo; Xiaomin Ren; Shaoliang Chen
Journal:  Int J Mol Med       Date:  2016-02-18       Impact factor: 4.101

10.  Lithium reduces blood glucose levels, but aggravates albuminuria in BTBR-ob/ob mice.

Authors:  Theun de Groot; Lars Damen; Leanne Kosse; Mohammad Alsady; Rosalinda Doty; Ruben Baumgarten; Susan Sheehan; Johan van der Vlag; Ron Korstanje; Peter M T Deen
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.